News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
CORRIGAN MARK
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/09/2023 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Wave Life Sciences Ltd.
Txns:
| Granted 45,000 options to buy
@ $4.58, valued at
$206.1k
|
|
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/04/2022 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Sold 10,297 shares
@ $0.19, valued at
$2k
|
|
08/18/2021 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Wave Life Sciences Ltd.
Txns:
| Granted 21,000 options to buy
@ $5.97, valued at
$125.4k
|
|
07/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/20/2020 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Wave Life Sciences Ltd.
Txns:
| Granted 10,500 options to buy
@ $9.13, valued at
$95.9k
|
|
09/06/2019 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Wave Life Sciences Ltd.
Txns:
| Granted 21,000 options to buy
@ $21.03, valued at
$441.6k
|
|
08/01/2019 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Granted 35,000 options
@ $0 |
|
08/13/2018 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns:
| Granted 50,000 options to buy
@ $0 |
|
05/04/2018 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Granted 29,000 options
@ $0 |
|
09/19/2017 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Granted 10,100 options
@ $0 |
|
06/27/2017 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on Nabriva Therapeutics Plc
Txns:
| Acquired 20,200 options
@ $0 Acquired 10,100 options
@ $0 |
|
03/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/12/2016 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.
Txns:
| Granted 8,897 options to buy
@ $6.24, valued at
$55.5k
|
|
10/29/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/08/2015 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.
Txns:
| Granted 9,000 options to buy
@ $6.39, valued at
$57.5k
|
|
01/21/2015 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Disposed of 7,501 shares
@ $102, valued at
$765.1k
Disposed/sold 16,519 options to buy
@ $21.01, valued at
$347.1k
Disposed/sold 9,472 options to buy
@ $38.06, valued at
$360.5k
Disposed/sold 9,367 options to buy
@ $41.2, valued at
$385.9k
Disposed/sold 8,370 options to buy
@ $50.24, valued at
$420.5k
Disposed/sold 6,202 options to buy
@ $66.68, valued at
$413.5k
Disposed/sold 1,687 restricted stock units
@ $0 |
|
07/17/2014 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.
Txns:
| Paid exercise price by delivering 14,597 shares
@ $11.8, valued at
$172.2k
|
|
06/05/2014 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Granted 899 shares
@ $0 Granted 6,202 options to buy
@ $66.68, valued at
$413.5k
Granted 1,687 restricted stock units
@ $0 Exercised 1,104 restricted stock units
@ $0 |
|
02/28/2014 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Sold 5,000 shares
@ $80, valued at
$400k
Exercised 5,000 options to buy
@ $18.22, valued at
$91.1k
|
|
02/12/2014 |
4
| CORRIGAN MARK (President & CEO) has filed a Form 4 on Zalicus Inc.
Txns:
| Granted 250,000 shares
@ $0 Granted 250,000 options to buy
@ $1.47, valued at
$367.5k
|
|
01/17/2014 |
4
| CORRIGAN MARK (President & CEO) has filed a Form 4 on Zalicus Inc.
Txns:
| Paid exercise price by delivering 18,079 shares
@ $1.66, valued at
$30k
|
|
01/07/2014 |
4
| CORRIGAN MARK (President & CEO) has filed a Form 4 on Zalicus Inc.
Txns:
| Paid exercise price by delivering 8,035 shares
@ $1.22, valued at
$9.8k
|
|
06/14/2013 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Granted 995 shares
@ $0 Granted 8,370 options to buy
@ $50.24, valued at
$420.5k
Granted 1,104 restricted stock units
@ $0 |
|
06/11/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/29/2013 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Sold 14,000 shares
@ $54.6044, valued at
$764.5k
Exercised 14,000 options to buy
@ $18.22, valued at
$255.1k
|
|
01/07/2013 |
4
| CORRIGAN MARK (President & CEO) has filed a Form 4 on Zalicus Inc.
Txns:
| Granted 250,000 shares
@ $0 Granted 500,000 options to buy
@ $0.76, valued at
$380k
|
|
07/26/2012 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $41.0075, valued at
$410.1k
Exercised 10,000 options to buy
@ $17.78, valued at
$177.8k
|
|
06/11/2012 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns:
| Granted 873 shares
@ $0 Granted 9,367 options to buy
@ $41.2, valued at
$385.9k
Granted 1,347 restricted stock units
@ $0 |
|
01/27/2012 |
4
| CORRIGAN MARK (President & CEO) has filed a Form 4 on Zalicus Inc.
Txns:
| Granted 100,774 options to buy
@ $1.13, valued at
$113.9k
Granted 799,226 options to buy
@ $1.13, valued at
$903.1k
|
|
01/19/2012 |
4
| CORRIGAN MARK (President & CEO) has filed a Form 4 on Zalicus Inc.
Txns:
| Sold 68,105 shares
@ $1.14, valued at
$77.6k
|
|
|
|
|